25 related articles for article (PubMed ID: 24947414)
1. High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma.
Theocharis S; Giaginis C; Gourzi S; Alexandrou P; Tsourouflis G; Sarantis P; Danas E; Michail A; Tsoukalas N; Pergaris A; Politis PK; Nakopoulou L
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829293
[TBL] [Abstract][Full Text] [Related]
2. SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition.
Bae JS; Noh SJ; Kim KM; Park SH; Hussein UK; Park HS; Park BH; Ha SH; Lee H; Chung MJ; Moon WS; Cho DH; Jang KY
Front Oncol; 2018; 8():538. PubMed ID: 30524965
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines.
Koobotse M; Holly J; Perks C
Oncotarget; 2018 Sep; 9(71):33562-33576. PubMed ID: 30323899
[TBL] [Abstract][Full Text] [Related]
4. Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.
Zhang X; Hofmann S; Harbeck N; Jeschke U; Sixou S
Drugs R D; 2017 Dec; 17(4):569-583. PubMed ID: 28879638
[TBL] [Abstract][Full Text] [Related]
5. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.
Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S
Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873
[TBL] [Abstract][Full Text] [Related]
6. Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.
Kim KM; Moon YJ; Park SH; Park HJ; Wang SI; Park HS; Lee H; Kwon KS; Moon WS; Lee DG; Kim JR; Jang KY
PLoS One; 2016; 11(9):e0163193. PubMed ID: 27643881
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancer.
Jiao F; Hu H; Han T; Zhuo M; Yuan C; Yang H; Wang L; Wang L
Oncotarget; 2016 Mar; 7(13):16505-16. PubMed ID: 26918727
[TBL] [Abstract][Full Text] [Related]
8. Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.
Park SH; Noh SJ; Kim KM; Bae JS; Kwon KS; Jung SH; Kim JR; Lee H; Chung MJ; Moon WS; Kang MJ; Jang KY
Transl Oncol; 2015 Aug; 8(4):239-49. PubMed ID: 26310369
[TBL] [Abstract][Full Text] [Related]
9. Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer.
Santivasi WL; Wang H; Wang T; Yang Q; Mo X; Brogi E; Haffty BG; Chakravarthy AB; Xia F
Br J Cancer; 2015 Jul; 113(3):453-9. PubMed ID: 26057449
[TBL] [Abstract][Full Text] [Related]
10. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
11. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters.
Lee WY; Jin YT; Chang TW; Lin PW; Su IJ
Histopathology; 1999 Feb; 34(2):106-12. PubMed ID: 10064388
[TBL] [Abstract][Full Text] [Related]
14. Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation.
Richardson J; Shaaban AM; Kamal M; Alisary R; Walker C; Ellis IO; Speirs V; Green AR; Bell SM
Breast Cancer Res Treat; 2011 Jun; 127(3):639-48. PubMed ID: 20632086
[TBL] [Abstract][Full Text] [Related]
15. [Expression of BRCA1 and WWOX and their clinicopathologic implication in breast carcinomas occurring in young women].
Zhang QL; Zhang QH; Cong H; Zhang XL
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):90-4. PubMed ID: 23710914
[TBL] [Abstract][Full Text] [Related]
16. Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas.
Mylona E; Melissaris S; Nomikos A; Theohari I; Giannopoulou I; Tzelepis K; Nakopoulou L
Pathol Res Pract; 2014 Aug; 210(8):533-40. PubMed ID: 24947414
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
